ARROWHEAD PHARMACEUTICALS, INC. Logo

ARROWHEAD PHARMACEUTICALS, INC.

Biotechnology company developing RNAi therapies to treat intractable diseases.

ARWR | US

Overview

Corporate Details

ISIN(s):
US04280A1007
LEI:
Country:
United States of America
Address:
177 E COLORADO BLVD, 91105 PASADENA

Description

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 22:54
S-3ASR
English 385.2 KB
2025-12-10 00:04
FORM 4
English 7.6 KB
2025-12-05 22:00 English 7.0 KB
2025-12-02 00:10
FORM 4
English 6.9 KB
2025-11-28 19:19 English 6.9 KB
2025-11-25 22:13
10-K
English 6.8 MB
2025-11-25 22:10
8-K
English 165.1 KB
2025-11-18 20:49
8-K
English 8.1 MB
2025-10-10 22:02
10-K/A
English 636.4 KB
2025-10-04 00:15
FORM 4
English 7.6 KB
2025-10-01 21:44 English 7.4 KB
2025-09-17 00:06
FORM 4
English 7.1 KB
2025-09-12 22:33 English 7.3 KB
2025-09-12 22:01
8-K
English 62.8 MB
2025-09-11 13:31
8-K
English 71.2 MB

Automate Your Workflow. Get a real-time feed of all ARROWHEAD PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ARROWHEAD PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ARROWHEAD PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ALNYLAM PHARMACEUTICALS, INC. Logo
A biopharmaceutical company developing RNA interference (RNAi) therapeutics.
United States of America
ALNY
Alpha Cognition Inc. Logo
A biopharmaceutical company developing treatments for neurodegenerative diseases.
United States of America
ACOG
Alpha Teknova, Inc. Logo
Manufacturer of critical reagents for the life sciences industry.
United States of America
TKNO
ALTERITY THERAPEUTICS LTD Logo
A clinical-stage biotech developing novel treatments for neurodegenerative diseases.
United States of America
ATHE
Altimmune, Inc. Logo
Clinical-stage biopharma developing peptide therapeutics for obesity and liver diseases.
United States of America
ALT
Alto Neuroscience, Inc. Logo
Develops precision medicines for neuropsychiatric conditions using patient biology.
United States of America
ANRO
ALUMIS INC. Logo
Clinical-stage biopharma developing precision medicines for autoimmune diseases.
United States of America
ALMS
Alvotech Holdings S.A Logo
A biotechnology company developing and manufacturing biosimilar medicines worldwide.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage immuno-oncology company developing therapies to combat cancer.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Develops treatments for neurodegenerative diseases and psychiatric disorders.
United States of America
ALZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.